Breaking News

Biotech VCs move upstream in China's scientific pipelines

March 31, 2026
Adobe

STAT+ | Biotech VCs move upstream in China's scientific pipelines as competition grows fiercer

U.S. and Chinese VCs court scientists pre-publication, racing to lock up IP early as competition intensifies and China's biotech boom accelerates.

By Brian Yang


STAT+ | Why this Stanford psychiatrist thinks diet can influence serious mental health disorders

Stanford psychiatrist Shebani Sethi studies how diet can impact serious mental health disorders such as schizophrenia, and depression.

By O. Rose Broderick


STAT+ | Merck to buy Terns Pharmaceuticals in $6.7B deal

The deal's centerpiece is a promising leukemia drug, which could help Merck offset the impending decline of Keytruda revenue.

By Adam Feuerstein



Molly Ferguson/STAT

STAT+ | Allogene's off-the-shelf CAR-T is nearing an early but pivotal study readout

In this week's edition of "Adam's Biotech Scorecard," Adam takes a look at Allogene's study, as well as two biotech CEOs in a very public spat.

By Adam Feuerstein


More around STAT

In case you missed it

  • Vaping is likely to cause lung and oral cancer, a new study finds, the Guardian
  • EPA moves to roll back recent limits on ethylene oxide, a carcinogen, Los Angeles Times
  • Sugar the Surfing Dog, the first canine inducted into the Surfer's Hall of Fame, dies of cancer, Associated Press

Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Cancer Briefing? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2026, All Rights Reserved.

No comments